Fig. 1From: Improvement in circulating endothelial progenitor cells pool after cardiac resynchronization therapy: increasing the list of benefitsEPCs levels according to ischemic or non-ischemic etiology. a Comparison of circulating levels of angiogenic CD34+ and CD133+ cells between ischemic and non-ischemic patients. b Comparison of CD34+KDR+ and CD133+KDR+ EPCs levels between ischemic and non-ischemic patients. EPCs, endothelial progenitor cellsBack to article page